cystamine has been researched along with Lupus Erythematosus, Systemic in 7 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cystamine treatment was performed by daily intraperitoneal administration." | 1.38 | Cystamine attenuates lupus-associated apoptosis of ventricular tissue by suppressing both intrinsic and extrinsic pathways. ( Chen, TY; Chiang, SY; Hsu, TC; Kao, SH; Kuo, CY; Li, SL; Tzang, BS, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, TC | 7 |
| Chiu, CC | 1 |
| Wang, YW | 1 |
| Tzang, BS | 7 |
| Wang, HP | 1 |
| Hsu, GJ | 1 |
| Li, SL | 4 |
| Kao, SH | 3 |
| Yu, JS | 1 |
| Chen, JT | 1 |
| Lai, WX | 3 |
| Kuo, CY | 1 |
| Chen, TY | 2 |
| Chiang, SY | 3 |
| Huang, CY | 2 |
| Tsai, CH | 1 |
| Tsai, CC | 1 |
| Wu, JH | 1 |
7 other studies available for cystamine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Effects of cystamine on antioxidant activities and regulatory T cells in lupus-prone mice.
Topics: Animals; Antioxidants; Cystamine; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Glutath | 2013 |
Cystamine attenuates the expressions of NOS- and TLR-associated molecules in the brain of NZB/W F1 mice.
Topics: Animals; Brain; Cyclin-Dependent Kinase Inhibitor p21; Cystamine; Disease Models, Animal; Female; Ge | 2009 |
Proteomic analysis for the anti-apoptotic effects of cystamine on apoptosis-prone macrophage.
Topics: Animals; Apoptosis; Cystamine; Electrophoresis, Gel, Two-Dimensional; Enzyme Inhibitors; Enzyme-Link | 2010 |
Cystamine attenuates lupus-associated apoptosis of ventricular tissue by suppressing both intrinsic and extrinsic pathways.
Topics: Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-Associated Death Protein; BH3 Intera | 2012 |
Cystamine ameliorates ventricular hypertrophy associated with modulation of IL-6-mediated signaling in lupus-prone mice.
Topics: Animals; Anti-Inflammatory Agents; Cystamine; Female; GTP-Binding Proteins; Heart Ventricles; Hypert | 2013 |
Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cystamine; Disease Models, Animal; Enzym | 2008 |
Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; BH3 Interacting Domain Death Agonist Protein; Casp | 2008 |